Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks

Sapacitabine is an orally bioavailable prodrug of the nucleoside analog 2′-C-cyano-2′-deoxy-1-β-D-arabino-pentofuranosylcytosine (CNDAC). Both the prodrug and active metabolite are in clinical trials for hematologic malignancies and/or solid tumors. CNDAC has a unique mechanism of action: after inco...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu, Xiao-Jun, Nowak, Billie, Wang, Ya-Qing, Plunkett, William
Format: Artigo
Language:Inglês
Published: Sun Yat-sen University Cancer Center 2012
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3777512/
https://ncbi.nlm.nih.gov/pubmed/22739266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.012.10077
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items